Peter Wiklund, MD, PhD, Professor of Urology in the Department of Urology at the Icahn School of Medicine at Mount Sinai and Director of the Bladder Cancer Program at the Mount Sinai Health System
Despite its complexity and its association with significant morbidity, open retroperitoneal lymph node dissection (RPLND) remains the standard of care for select-stage patients who present with testicular cancer. But Mount Sinai urologists are exploring the potential of using a different approach for this technically challenging surgery: robot-assisted RPLND.
Peter Wiklund, MD, PhD
